EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

UPLC-MS/MS method for Icariin and metabolites in whole blood of C57 mice: development, validation, and pharmacokinetics study

Wei Liu, Xiuyun Li, Na Li, Ze Mi, Na Li, Jinjing Che

Frontiers in Pharmacology · 20.07.2023 · 14

DOI: 10.3389/fphar.2023.1195525 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Pharmacology, online erschienen am 20.07.2023. Verfasst von Wei Liu und 5 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Separation Membranes and Membrane Processes/National Center for International Joint Research on Separation Membranes, Tiangon…. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Icariin, a Chinese medicinal herb with significant effects on Alzheimer’s disease, lacks pharmacokinetic data in mice. To address this, a UPLC-MS/MS method was developed and validated for quantifying Icariin and its metabolites, Icariside I and Icariside II, in the whole blood of mice. The method processed micro-whole blood from serial collections of the same C57 mouse, with well-fitted linearity (0.25–800 ng mL −1 ) and intra- and inter-day precision and accuracy within 15%. Short-time and autosampler stability were verified, with acceptable extraction recoveries and matrix effects over 74.55%. After intravenous administration (15 mg kg −1 ) of Icariin in C57 mice, Icariside I and Icariside II were detected within 2 min. However, after the intragastric administration (30, 90, and 150 mg kg −1 ) of Icariin in C57 mice, Icariin and Icariside I were not detected, and Icariin was rapidly converted into Icariside II. Furthermore, the C max and AUC 0-t of three doses (30, 90, and 150 mg kg -1 ) of Icariside II increased as the dose increased. In conclusion, this method improves the traditional method of collecting only one blood sample from each mouse, detecting Icariin and its metabolites in the whole blood of mice, especially for serial collection of micro-whole blood.

Schlagwörter

Stichwörter der Autor:innen

IcariinIcariside IIcariside IIUPLC-MS/MSpharmacokineticsserial whole blood sampling

Autor:innen und Institutionen

  • State Key Laboratory of Separation Membranes and Membrane Processes/National Center for International Joint Research on Separation Membranes, Tiangong University, Tianjin, China.
  • Beijing Institute of Pharmacology and Toxicology, State Key Laboratory of Toxicology and Medical Countermeasures Beijing, Beijing, China.
  • Center of Drug Evaluation, National Medical Products Administration, Beijing, China.

Zitieren

APA

Liu, W., Li, X., Li, N., Mi, Z., Li, N., & Che, J. (2023). UPLC-MS/MS method for Icariin and metabolites in whole blood of C57 mice: development, validation, and pharmacokinetics study. Frontiers in Pharmacology, 14. https://doi.org/10.3389/fphar.2023.1195525

Vancouver

Liu W, Li X, Li N, Mi Z, Li N, Che J. UPLC-MS/MS method for Icariin and metabolites in whole blood of C57 mice: development, validation, and pharmacokinetics study. Frontiers in Pharmacology. 2023;14. doi:10.3389/fphar.2023.1195525

BibTeX
@article{Liu2023,
  author = {Liu, Wei and Li, Xiuyun and Li, Na and Mi, Ze and Li, Na and Che, Jinjing},
  title = {UPLC-MS/MS method for Icariin and metabolites in whole blood of C57 mice: development, validation, and pharmacokinetics study},
  journal = {Frontiers in Pharmacology},
  year = {2023},
  volume = {14},
  doi = {10.3389/fphar.2023.1195525}
}
Kostenlos starten →